-
Lilly: We have applied to the FDA for the weight loss drug Zepbound to treat sleep apnea, and it is expected to be approved as early as the end of the year
According to AI News, according to CNBC, Lilly has applied to the United States for approval of its weight loss drug Zepbound for the treatment of the most common sleep related respiratory disorders, ...